Synthesis of novel 1-(2,3-dihydro-5H-4,1-benzoxathiepin-3-yl)-uracil and -thymine, and their corresponding S-oxidized derivatives

Tetrahedron

Volumn 61, Issue 43, 2005, Pages 10363-10369

  Del Carmen Nunez M ^a   Entrena, Antonio ^a   Rodríguez Serrano, Fernando ^b   Marchal, Juan A ^c   Aránega, Antonia ^d   Gallo, Miguel Á ^a   Espinosa, Antonio ^a   Campos, Joaquín M ^a  

^a Facultad de Farmacia   (Spain)

^b UNIVERSITY OF GRANADA   (Spain)

^c Facultad de CC Experimentales   (Spain)

^d UNIVERSITY OF GRANADA   (Spain)

Author keywords

Antitumour compounds; Benzoxathiepins; Computer assisted methods; Uracils

Indexed keywords

1 (1 OXO 3,5 DIHYDRO 2H 4,1 BENZOXATHIEPIN 3 YL)THYMINE; 1 (2,3 DIHYDRO 5H 1,4 BENZODIOXEPIN 3 YL) 5 FLUOROURACIL; 1 (2,3 DIHYDRO 5H 4,1 BENZOXATHIEPIN 3 YL)THYMINE; 1 (2,3 DIHYDRO 5H 4,1 BENZOXATHIEPIN 3 YL)URACIL; 3 (1,1 DIOXO 2,3 DIHYDRO 5H 4,1 BENZOXATHIEPIN 3 YL)THYMINE; 3 (2,3 DIHYDRO 5H 4,1 BENZOXATHIEPIN 3 YL)THYMINE; 3 (2,3 DIHYDRO 5H 4,1 BENZOXATHIEPIN 3 YL)URACIL; ACETAL DERIVATIVE; ANTINEOPLASTIC AGENT; FLUOROURACIL DERIVATIVE; SULFOXIDE; THYMINE DERIVATIVE; UNCLASSIFIED DRUG; URACIL DERIVATIVE;

ARTICLE; CANCER GROWTH; CELL STRAIN MCF 7; CONFORMATION; CONTROLLED STUDY; DRUG STRUCTURE; DRUG SYNTHESIS; HUMAN; HUMAN CELL; ISOMER; MOLECULAR BIOLOGY; MOLECULE; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE;

MINK CELL FOCUS-FORMING VIRUS;

EID: 25144467016     PISSN: 00404020     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tet.2005.07.065     Document Type: Article

References (15)

1. E. Saniger, J. Campos, A. Entrena, J.A. Marchal, I. Súarez, A. Aránega, D. Choquesillo, J. Niclós, M.A. Gallo, and A. Espinosa Tetrahedron 59 2003 5457 5467
2. E. Saniger, J. Campos, A. Entrena, J.A. Marchal, B. Houria, A. Aránega, M.A. Gallo, and A. Espinosa Tetrahedron 59 2003 8017 8026
3. J. Campos, J.F. Domínguez, M.A. Gallo, and A. Espinosa Curr. Pharm. Des. 6 2000 1797 1810
4. L. Crombie, J.L. Josephs, J. Larkin, and J.B. Weston Chem. Soc., Chem. Commun. 14 1991 972 973
5. For reviews, see: (a) R.S. Ward, and R. Diaper Sulfur Rep. 22 2001 251
6. D.A. Jackson, H. Rawlinson, and O. Barba Spec. Publ.-R. Soc. Chem. 260 2001 47 53
7. A.V. Mashkina Sulfur Rep. 10 1991 279 388
8. M. Matteucci, G. Bhalay, and M. Bradley Org. Lett. 5 2003 235 237
9. S.P. Khanapure, D.S. Garvey, D.V. Young, M. Ezawa, R.A. Earl, R.D. Gaston, X. Fang, M. Murty, A. Martino, M. Shumway, M. Trocha, P. Marek, S.W. Tam, D.R. Janero, and L.G. Letts J. Med. Chem. 46 2003 5484 5504
10. From now on, the primes (′) will accompany the numbering of the pyrimidine bases.
11. A. Bax, and M.F. Summers J. Am. Chem. Soc. 108 1986 2093 2094
12. S. Matsuo, S. Tanako, J. Yamashita, and M. Ogawa Anticancer Res. 12 2000 1575 1579
13. A. Trouet, A. Passioukov, K.V. Derpooten, A.M. Fernández, J. Abarca-Quiñones, R. Baurain, T.J. Lobl, C. Oliyai, and V. Dubois Cancer Res. 61 2001 2843 2846
14. M. Díaz-Gavilán, F. Rodríguez-Serrano, J.A. Gómez-Vidal, J.A. Marchal, A. Aránega, M.A. Gallo, A. Espinosa, and J.M. Campos Tetrahedron 60 2004 11547 11557
15. E. Saniger, M. Díaz-Gavilán, B. Delgado, D. Choquesillo, J.M. González-Pérez, S. Aiello, M.A. Gallo, A. Espinosa, and J.M. Campos Tetrahedron 60 2004 11453 11464